지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
Gut and Liver
2017 .01
만성 C형간염에서 페그인터페론과 리바비린의 병합치료 시 지속바이러스반응에 대한 순응도의 효과
Clinical and Molecular Hepatology
2009 .01
Chronic Hepatitis C
Gut and Liver
2011 .01
Durability of Sustained Virologic Response in Chronic Hepatitis C
Gut and Liver
2013 .01
Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
Gut and Liver
2018 .01
유전자형 1형 만성 C형 간염 환자에서 혈청 인터페론감마유도단백질-10의 의미
대한내과학회지
2010 .01
만성 C형간염에서 인터페론/페그인터페론과 리바비린 병합요법 후 지속바이러스반응 유지에 대한 고찰
Clinical and Molecular Hepatology
2009 .01
우리나라 만성 C형간염 환자에서 페그인터페론과 리바비린의 병합치료에 대한 효과
Clinical and Molecular Hepatology
2008 .01
유전자 2형인 만성 C형간염 환자에서 페그인터페론과 리바비린의 단기간 치료 효과
Clinical and Molecular Hepatology
2007 .01
만성 C형 간염에서 아포지단백E 유전자형과 치료반응과의 관련성
Annals of Clinical Microbiology
2013 .01
Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
Gut and Liver
2016 .01
Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
Gut and Liver
2015 .01
Role of Interleukin-28B Genetic Polymorphisms in Korean Patients with Hepatitis C Virus Infection
Gut and Liver
2014 .01
Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
Gut and Liver
2016 .01
Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study
Gut and Liver
2016 .01
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
Clinical and Molecular Hepatology
2014 .01
Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Clinical and Molecular Hepatology
2019 .01
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Clinical and Molecular Hepatology
2012 .01
No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
Clinical and Molecular Hepatology
2014 .01
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
Clinical and Molecular Hepatology
2011 .01
0